Abstract

Human UC-MSCs are regarded as an attractive alternative to BM-MSCs for clinical applications due to their easy preparation, higher proliferation and lower immunogenicity. However, the mechanisms underlying immune suppression by UC-MSCs are still unclear. We studied the mechanism of inhibition by UC-MSCs during the differentiation of monocytes into DCs and focused on the specific source and the role of the involved cytokines. We found that UC-MSCs suppressed monocyte differentiation into DCs and instructed monocytes towards other cell types, with clear decreases in the expression of co-stimulatory molecules, in the secretion of inflammatory factors and in allostimulatory capacity. IL6, HGF and IL10 might be involved in this process because they were detected at higher levels in a coculture system. UC-MSCs produce IL-6 and HGF, and neutralization of IL-6 and HGF reversed the suppressive effect of UC-MSCs. IL10 was not produced by UC-MSCs but was exclusively produced by monocytes after exposure to UC-MSCs, IL-6 or HGF. In summary, we found that the UC-MSC-mediated inhibitory effect was dependent on IL6 and HGF secreted by UC-MSCs and that this effect induced monocyte-derived cells to produce IL10, which might indirectly strengthen the suppressive effect of UC-MSCs.

Highlights

  • Aspiration of bone marrow is difficult and involves invasive procedures, which restrict the application of BM-MSCs

  • We found that umbilical cord (UC)-MSCs suppressed monocyte differentiation into DCs and instructed monocytes towards IL10-producing cell types, with a clear decrease in the expression of co-stimulatory molecules, in the secretion of inflammatory factors and in allostimulatory capacity

  • We found that the UC-MSC-mediated inhibitory effect was dependent on IL6 and HGF and that this effect subsequently induced monocyte-derived cells to produce IL10, which might indirectly strengthen the suppressive effect of UC-MSCs

Read more

Summary

Introduction

Aspiration of bone marrow is difficult and involves invasive procedures, which restrict the application of BM-MSCs. Compared with MSCs isolated from bone marrow, UC-MSCs offer distinct advantages, including easier accessibility, more primitive properties, higher proliferation capacity and lower immunogenicity[13]. Due to these advantages, UC-MSCs are being explored as a promising candidate for many potential clinical applications. We found that UC-MSCs suppressed monocyte differentiation into DCs and instructed monocytes towards IL10-producing cell types, with a clear decrease in the expression of co-stimulatory molecules, in the secretion of inflammatory factors and in allostimulatory capacity. We found that the UC-MSC-mediated inhibitory effect was dependent on IL6 and HGF and that this effect subsequently induced monocyte-derived cells to produce IL10, which might indirectly strengthen the suppressive effect of UC-MSCs

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call